Vaia Lambadiari

16PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyImmunogenetics (incl. genetic immunology)Medical biochemistry - lipidsMedical genetics (excl. cancer genetics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 02, 2026
Myocardial deformation links combined liraglutide-empagliflozin therapy with improved cardiovascular and economic outcomes in type 2 diabetes: a 6-year study.

|Oct 13, 2025
Metreleptin In SHORT Syndrome With Uncontrolled Diabetes.

Emmanouil Korakas, Aikaterini Kountouri, Ignatios Ikonomidis

|Feb 25, 2025
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance.

Maria Apostolopoulou, Vaia Lambadiari, Michael Roden

|Jul 09, 2024
Semaglutide Concurrently Improves Vascular and Liver Indices in Patients With Type 2 Diabetes and Fatty Liver Disease.

Emmanouil Korakas, Aikaterini Kountouri, George Pavlidis

|Mar 21, 2023
Additive prognostic value of longitudinal myocardial deformation to SCORE2 in psoriasis.

George Makavos, Ignatios Ikonomidis, Vaia Lambadiari

|Dec 06, 2021
Diagnostic Performance of Frequency-Domain Optical Coherence Tomography to Predict Functionally Significant Left Main Coronary Artery Stenosis.

Konstantina P Bouki, Delia I Vlad, Nikolaos Goulas

Pageof 3

Frequent Collaborators

7 joint publications

Ignatios Ikonomidis

5 joint publications

Konstantinos Katogiannis

3 joint publications

Emmanouil Korakas

3 joint publications

Aikaterini Kountouri